Skip to main content
English
中文
Log In
Log in
Log in with ORCID
NTU Single Sign On
New user? Click here to register.
Have you forgotten your password?
Home
.National Taiwan University / 國立臺灣大學
Project / 研究計畫
(100CAP020-2) In vivo Resistant Mechanisms of Sorafenib in Hepatocellular Carcinoma (HCC)---Development of Predictive Biomarkers and Resistance-Reversing Strategies (II)
(100CAP020-2) In vivo Resistant Mechanisms of Sorafenib in Hepatocellular Carcinoma (HCC)---Development of Predictive Biomarkers and Resistance-Reversing Strategies (II)
Details
Primary Data
Project title
超越Sorafenib---探詢肝細胞癌的新穎治療標的及生物指標-(子計畫二)肝細胞癌對Sorafenib具抗藥性的活體實驗模式:著重預測生物標記及抗藥性反轉策略之研發(II)
Internal ID
NSC101-2325-B002-040
Principal Investigator
CHIH-HUNG HSU
Start Date
May 1, 2012
End Date
April 12, 2013
Partner Organizations
National Science and Technology Council
Project Web Site
http://grbsearch.stpi.narl.org.tw/search/planDetail2?id=2548601